HLTH5453 Module 6 policy brief example

Reviewed by Cornelius Ravenhill, MBA · American College of Education · True APA form, annotated

This page holds a complete HLTH 5453 Module 6 example in true APA form: a policy brief for American College of Education's Health Policy Evaluation and Development course. It compresses a term's analysis of the 340B Drug Pricing Program into a short brief addressed to a composite health policy advisor on a Senate committee, leading with the recommendation, giving only the evidence the reader needs and anticipating the objections the advisor will hear.

1

Policy Brief: Make 340B Savings Visible Without Cutting Them

Student Name

American College of Education

HLTH5453: Health Policy Evaluation and Development

Module 6 Assignment

Instructor Name

December 6, 2027

What this page is doingThe title is written as the recommendation itself, which is the convention for policy briefs: a busy reader should know the ask from the title alone. The APA 7 title page carries the course line and module assignment as listed, and the memo header inside the paper identifies the composite recipient.
2

Memo Header and Bottom Line

To: Health policy advisor, Senate committee with jurisdiction over the Public Health Service Act (composite recipient for this assignment). From: Graduate student, health administration. Date: December 6, 2027. Re: A reporting requirement for hospitals in the 340B Drug Pricing Program.

Bottom line: The 340B program reliably increases revenue for participating hospitals, but there is no strong evidence that this revenue reaches the low-income patients the program is commonly understood to serve, and no one can check, because hospitals do not have to report their savings or how they use them. We recommend a statutory amendment requiring participating hospitals to disclose each year what the discount earns them, payer by payer, and where the money goes, using the categories they already file for community benefit, and to lose program eligibility if they do not. The amendment cuts no one's benefits. It asks hospitals to show what the program does, which the strongest defenders of the program should welcome.

What this page is doingThe memo header identifies the recipient as a composite, and the bottom line states the problem, the recommendation and its most persuasive feature in four sentences. A reader who stops here knows what is being asked and why.
3

Why This Matters Now

The program has grown far beyond its early scale, with many more hospitals and thousands of contract pharmacies now participating, and it faces pressure from all sides: manufacturers restricting contract pharmacy pricing, litigation in several states and repeated congressional hearings. In that environment, the absence of data works against everyone. Hospitals cannot demonstrate the good they do with the program, critics cannot be answered with evidence and Congress has to legislate without knowing what the program delivers.

4

What the Evidence Shows

Three findings matter most. First, a strong study design comparing hospitals just above and below the eligibility threshold found that eligibility led to more hospital-employed oncologists and more hospital-billed infused drugs, but not to clear increases in care for low-income patients or lower mortality in their communities (Desai & McWilliams, 2018). Second, after entering the program, hospitals raised charity care spending by roughly 29 percent, yet overall community benefit spending stayed flat, which points to cuts somewhere else (Nikpay et al., 2020). Third, federal auditors have found that oversight of the program, especially at contract pharmacies, is limited (U.S. Government Accountability Office [GAO], 2018). Together these findings show a program that works as a financial mechanism and cannot yet demonstrate its purpose.

What this page is doingThe evidence is compressed to three findings, each in one sentence with its source, and a one-sentence synthesis. The brief does not explain research designs beyond a phrase, because its reader needs the conclusion and the confidence behind it, not the method.
5

The Ask

We recommend legislative language with four elements. First, participating hospitals, but not federal grantees such as community health centers, report annual 340B savings, broken out by payer type, and disclose whether they carve Medicaid out of 340B purchasing. Second, hospitals report the use of savings in categories that match their existing community benefit reporting to the Internal Revenue Service. Third, any hospital that does not report loses eligibility, with the administering agency handling enforcement within its current compliance procedures. Fourth, the agency publishes the reports in a standard format each year.

We do not recommend using Medicare payment to enforce reporting. After the Supreme Court held that Medicare could not cut payment rates for 340B hospitals without first completing a required survey of acquisition costs (American Hospital Association v. Becerra, 2022), a payment-based penalty would invite litigation and delay.

6

What You Will Hear, and What to Say

Hospital associations will say reporting is burdensome. Aligning categories with reports hospitals already file limits the burden, and the requirement applies only to hospitals, not to small grantees. Some will say reporting is the first step toward cuts. The amendment contains no cuts, and data showing that savings support patient care would be the strongest defense against future cuts. Manufacturers will say reporting is not enough and eligibility should be narrowed. That is a separate debate that this amendment does not preclude, and it would be better informed by the data this amendment produces. Every side of the 340B debate claims to know what the program does; this amendment is the only proposal that would find out.

What this page is doingObjections are attributed to the groups likely to raise them and answered in one or two sentences each, in language an advisor could repeat in a meeting. The highlighted sentence gives the advisor a framing that positions the proposal above the partisan contest.
7

Cost and Feasibility

The amendment has little direct federal cost. The administering agency would need modest additional staff to build the reporting template, receive the reports and publish them, which could be funded through a small appropriation or a modest participation fee. For hospitals, the main cost is staff time to calculate savings by payer, work that many larger participants already do internally for their own financial planning. Because the categories for the use of savings match the community benefit schedule hospitals file with their tax returns, most of the reporting would draw on information already assembled each year. A phased start, beginning with the largest participating hospitals in the first year and extending to all hospitals in the second, would let the agency refine the template before every participant must use it.

8

Next Step

We would welcome thirty minutes with your staff to walk through draft legislative language and the reporting template, and we can provide a short list of hospitals and community health centers in the state that would speak to the proposal's workability.

9

References

American Hospital Association v. Becerra, 596 U.S. 724 (2022).

Desai, S., & McWilliams, J. M. (2018). Consequences of the 340B drug pricing program. New England Journal of Medicine, 378(6), 539-548. https://doi.org/10.1056/NEJMsa1706475

Nikpay, S. S., Buntin, M. B., & Conti, R. M. (2020). Relationship between initiation of 340B participation and hospital safety-net engagement. Health Services Research, 55(2), 157-169. https://doi.org/10.1111/1475-6773.13278

U.S. Government Accountability Office. (2018). Drug discount program: Federal oversight of compliance at 340B contract pharmacies needs improvement (GAO-18-480).

How this HLTH 5453 Module 6 example is structured

HLTH 5453 Module 6 usually compresses the case into a brief a decision maker could act on; your classroom's instructions decide the audience and length. This example uses a memo format with the recommendation first, then the problem, the evidence, the specific legislative ask, the likely objections with answers and the next step. Every section is shorter than the corresponding module earlier in the course, because the brief's reader has minutes, not hours. What is left out is as deliberate as what is kept: methods detail, the full power map and the stress test's reasoning appear only as conclusions.

HLTH5453 Module 6 questions, answered

What does HLTH5453 Module 6 usually ask for?

HLTH5453 Module 6 usually asks students to compress their policy analysis into a brief for a decision maker, such as a legislator, agency head or board. Many sections set a page limit and expect the recommendation to come first. Your classroom's instructions decide the audience, the length and whether APA formatting applies to the brief itself.

How is a policy brief different from a policy paper?

A policy brief puts the recommendation first, uses only the evidence the reader needs to act and anticipates objections the reader will face. A policy paper explains methods, reviews evidence fully and shows reasoning in detail. The brief should be readable in a few minutes; the paper is where the detail lives.

Should a policy brief include citations?

Yes, but sparingly. Cite the few sources that carry the key findings, so the reader can check them or share them, and keep the citation format simple. The brief's credibility depends on accurate evidence, even though it presents only the conclusions of that evidence.

Write yours, or have the desk draft it

This paper is an original model document written by our desk, not a submitted student paper and not an official American College of Education document. Read it for the moves, then write your own to the instructions in your classroom. If you want one built to your exact prompt and rubric, the first custom sample is free and arrives in 24 to 48 hours.